Prospective study assessing hypoxia-related proteins as markers for the outcome of treatment with sunitinib in advanced clear-cell renal cell carcinoma-Reference-Cited by-同舟云学术

Prospective study assessing hypoxia-related proteins as markers for the outcome of treatment with sunitinib in advanced clear-cell renal cell carcinoma

Published:2013-09 Issue:9 Volume:24 Page:2409-2414
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Garcia-Donas J.,Leandro-García L.J.,González del Alba A.,Morente M.,Alemany I.,Esteban E.,Arranz J.A.,Climent M.A.,Gallardo E.,Castellano D.E.,Bellmunt J.,Mellado B.,Puente J.,Moreno F.,Font A.,Hernando S.,Robledo M.,Rodríguez-Antona C.

Funder

Pfizer

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/24/9/2409/13790116/mdt219.pdf

Reference23 articles.

1. Epidemiologic and socioeconomic burden of metastatic renal cell carcinoma (mRCC): a literature review;Gupta;Cancer Treat Rev,2008

2. Treatment selection in metastatic renal cell carcinoma: expert consensus;Escudier;Nat Rev Clin Oncol,2012

3. Constitutional genetic variants as predictors of antiangiogenic therapy outcome in renal cell carcinoma;Rodriguez-Antona;Pharmacogenomics,2012